Genovate Biotechnology Co., Ltd. (GENOVATE BIOTECHNOLOGY CO. LTD.) aktie
4130.TWO
Stängt$25.85-0.45 (-1.71%)
Laddar diagram...
GENOVATE BIOTECHNOLOGY CO. LTD.
Market Cap
$3,534,987,520
Öppning24.10
Högsta26.00
Lägsta24.10
Volym121.39k
P/E258.50
Börsvärde3.53B
52 veckors högsta38.89
52 veckors lägsta17.65
Genomsnittlig volym1.07M
Utdelning0.37%
BetaN/A
EPS0.10
Om Genovate Biotechnology Co., Ltd. (GENOVATE BIOTECHNOLOGY CO. LTD.) aktie
Genovate Biotechnology Co., Ltd. engages in the research, development, manufacture, production, and sale of products to prevent and treat diseases caused by viruses and bacteria in Taiwan. It provides drugs, APIs, intermediates, and release agents for the treatment of cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune diseases; and controlled-release dosage forms of Western medicine, as well as cosmetics. Genovate Biotechnology Co., Ltd. was founded in 1982 and is based in Hsinchu City, Taiwan.
Företagsinformation
Börs: Taipei Exchange (TWO)
Sektor: Sundhed
Industri: Bioteknologi
Adress:
No. 1, Gongye 1st Road
30351 Hsinchu City, Taiwan
30351 Hsinchu City, Taiwan
Telefon: + 886 3 598 2221
Hemsida: https://www.genovate-bio.com
Analytikernas aktierekommendationer
Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.
Lägsta kursmål
Genomsnittligt kursmål
Median kursmål
Högsta kursmål